Pyridoxine Hydrochloride Tablet Market Share, Sales Channels and Overview Till 2028

The Global Pyridoxine Hydrochloride Tablet market is forecast to reach USD 731.5 Million by 2028, according to a new report by Reports and Data. Pyridoxine Hydrochloride Tablet can be described as a water-soluble B vitamin, which is the hydrochloride salt of Pyridoxine Hydrochloride Tablet. In 1934 Pyridoxine Hydrochloride Tablet was discovered, and in 1939 it was made artificially. It is included in the vitamin B family of vitamins.  The World Health Organization's List of Essential Medicines lists it as the most effective and safest medicines needed in a health system. When it is consumed as medication or in nutritional supplements in the liver, Pyridoxine Hydrochloride Tablet is converted into metabolically active coenzyme form pyridoxal 5'-phosphate (P5P). P5P is an important cofactor in various enzymatic reactions in amino acid metabolism, including deamination, transamination, and decarboxylation. P5P is necessary for glycogenolysis and the formation of sphingolipids. The immune system and neurological system both depend on it for proper operation. Important nutrients like vitamin B6 and Pyridoxine Hydrochloride Tablet are required for the body's numerous biological processes to operate normally. Although Pyridoxine Hydrochloride Tablet can be produced by a variety of microbes and plants through endogenous biological mechanisms, animals must take it through diet. Consequently, growing demand for dietary supplements and growing knowledge of the importance of eating a balanced diet are fostering the sector's expansion.

In terms of geography, North America accounted for a sizable portion of the market. The region's dominant pharmaceutical sector in countries like Canada, which offers significant room for the industry's expansion in this region, is credited with the market share it now holds.

Request Free Sample Copy @

Further key findings from the report suggest

  • The Pyridoxine Hydrochloride Tablet market held a market share of USD 408.0 Million in the year 2020 that is forecasted to grow at a rate of 8.0% during the forecast period.
  • In context to Form, the Liquid segment is projected to witness a faster growth rate of 8.7% during the forecast period, which occupied more than 35.0% of the market in 2020. The growth rate witnessed by the Liquid segment is attributed to the increasing demand for the vitamin in liquid form in the pharmaceutical sector due to its quick absorption and enhanced functioning as compared to its solid form, which results in its growing popularity.
  • In context to Grade, the Food Grade segment held the largest market share of more than 30.0% in 2020, with a CAGR of 8.2% during the forecast period. The market share held by the Food Grade segment is attributed to the applicability of the compound in the food beverage sector in reinforcing nutrition in the food industry along with its used as a nutritive additive in dairy products, soft drinks, and confectionary preservatives contributes to the market share held by this segment.
  • In regards to End-user, the Pharmaceutical segment is projected to witness the fastest growth rate of 8.5% during the forecast period, which is expected to hold 26.0% of the market by 2028. The growth rate witnessed by the Pharmaceutical segment is attributed to the continuous expansion of the healthcare sector, the associated elevating demand for medications, and applicability of the compound in this sector in preventing and treating sideroblastic anaemia, certain types of mushroom poisoning, Pyridoxine Hydrochloride Tablet-dependent epilepsy, and problems from isoniazid and Pyridoxine Hydrochloride Tablet deficiency among others.   
  • In regards to the region, Europe is projected to witness a considerable CAGR of 8.2% during the forecast period, which is expected to hold more than 25.0% of the market by 2028. The growth rate witnessed by Europe is attributed to the continuous growth of the food beverage sector, rising geriatric population, and expanding pharmaceutical industry along, which is supporting the expansion of the sector in this region.

Key Players covered in this report are

DSM Tianxin Pharmaceutical, Hegno, Huazhong Pharmaceutical, Nutra Healthcare, Guangji Pharmaceutical, AVANSCURE LIFESCIENCES PVT. LTD., BASF Human Nutrition, Amsar Private Limited, and A Z FOOD ADDITIVES CO., LTD.


Form Outlook (Volume, Kilo Tons; Revenue, USD Million; 2018-2028)

  • Solid
  • Liquid

Grade Outlook (Volume, Kilo Tons; Revenue, USD Million; 2018-2028)

  • Food Grade
  • Feed Grade
  • Pharmaceutical Grade

End-user Outlook (Volume, Kilo Tons; Revenue, USD Million; 2018-2028)

  • Food Beverage Industry
  • Animal Nutrition
  • Pharmaceutical Industry
  • Others

Geographic Segment Covered in the Report:

The Pyridoxine Hydrochloride Tablet report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

  • North America (USA and Canada)
  • Europe (UK, Germany, France and the rest of Europe)
  • Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
  • Latin America (Brazil, Mexico, and the rest of Latin America)
  • Middle East and Africa (GCC and rest of the Middle East and Africa)

Major Points covered in this report are as below:

• The Pyridoxine Hydrochloride Tablet industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.

• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

• Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.

• The Pyridoxine Hydrochloride Tablet Market report provides key statistics on the market status of the Pyridoxine Hydrochloride Tablet manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa

Request customization of the report @

We appreciate you reading our report. To learn more about the report and its customizable feature, please get in touch with us. Our team will make sure that your questions are answered and the report is tailored to your needs.

Get Explore Latest Research Report by Reports and Data:

Synthetic Biology Market @

Wound Care Market @

Virtual Reality in Healthcare Market @

Surgical Table Market @

Telehealth Market @

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web:

Direct Line: +1-212-710-1370

E-mail: [email protected]

amol shinde a

amol shinde

Comments (0)

You Must Be Logged In To Comment